Cannae Holdings, Inc. CNNE 深 沪
已收盘 03-27 16:00:00 美东时间
10.74
-0.280
-2.54%
华盛通- 最 高10.91
- 今 开10.88
- 成交量 63.94万股
- 最 低 10.645
- 昨 收 11.02
- 总市值 4.98亿
- 52周最高 21.51
- 市盈率 静 --
- 换手率 1.38%
- 52周最低 10.46
- 委 比 28.12%
- 总股本 4632.47万
- 历史最高 45.52
- 量 比 0.49
- 振 幅 2.40%
- 历史最低 10.46
- 每 手 1
- 风险率 2.55%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多新浪财经ESG：Cannae Holdings Inc. MSCI（明晟）ESG评级调升至BBB
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务，助力上市公司传播ESG理念，提升ESG可持续发展表现。点击查看【 ESG评级中...
03-24 10:15
Cannae increases share repurchase authorization to $10M
Cannae Holdings (CNNE) has authorized a new stock repurchase program, effective March 6, 2026, under which the company may repurchase up to 10 million shares of its common stock. This is in addition t...
03-09 20:01
Cannae Authorizes Buyback of Up to 10M Shares
Cannae Holdings, Inc. (NYSE:CNNE) ("Cannae" or the "Company") today announced that its Board of Directors has authorized a new stock repurchase program, effective March 6, 2026, under which the Company may repurchase up
03-09 19:40
Cannae Holdings authorizes stock buyback of up to 10 million shares
Cannae Holdings authorizes stock buyback of up to 10 million shares Cannae’s board authorized a new stock repurchase program under which it may repurchase up to 10 million shares of common stock. The authorization is in addition to 4.9 million shares remaining under prior repurchase authorizations,
03-09 19:30
美股大行评级 | 潜在涨幅243.25%！泰利克斯制药获花旗升目标价至22.5美元，维持"买入"评级
今日重点评级关注：花旗：维持Telix Pharmaceuticals"买入"评级，目标价从22美元升至22.5美元；摩根士丹利：维持Vir Biotechnology"超配"评级，目标价从20美元升至24美元
02-25 11:03
Cannae Holdings Earnings Call: Sports Pivot and Buybacks
Cannae Holdings, Inc. (($CNNE)) has held its Q4 earnings call. Read on for the ...
02-25 08:22
Cannae Holdings CEO Ryan Caswell Issues Shareholder Letter; Board Established New Set Of Strategic Priorities
Fellow Shareholders,Over the last year we have made substantial progress executing our strategic initiativesoutlined in 2024 designed to generate long-term shareholder value. Notable accomplishments in2025 include
02-24 05:16
Cannae Holdings Q4 EPS $(1.93) Misses $(0.38) Estimate, Sales $103.300M Beat $102.700M Estimate
Cannae Holdings (NYSE:CNNE) reported quarterly losses of $(1.93) per share which missed the analyst consensus estimate of $(0.38) by 414.67 percent. This is a 160.81 percent decrease over losses of $(0.74) per share from
02-24 05:13
Cannae Holdings Inc. announces availability of Q4 and full-year 2025 financial results letter to shareholders
Cannae Holdings Inc. announces availability of Q4 and full-year 2025 financial results letter to shareholders Cannae Holdings, Inc. announced it has posted its fourth quarter and full year 2025 financial results in its Letter to Shareholders at https://www.cannaeholdings.com . The company will host
02-24 05:11
CNNE Q4 revenue USD 653 million (-4%)
CNNE Q4 revenue USD 653 million (-4%) Cannae reported a Q4 2025 net loss attributable to shareholders of USD 93 million (USD 1.93 per share), versus a Q4 2024 net loss of USD 46.1 million (USD 0.74 per share). In FY 2025, net loss attributable to shareholders was USD 513.2 million (USD 9.08 per shar
02-24 05:10
